JP2009535298A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009535298A5 JP2009535298A5 JP2009502932A JP2009502932A JP2009535298A5 JP 2009535298 A5 JP2009535298 A5 JP 2009535298A5 JP 2009502932 A JP2009502932 A JP 2009502932A JP 2009502932 A JP2009502932 A JP 2009502932A JP 2009535298 A5 JP2009535298 A5 JP 2009535298A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cancer
- anticancer agent
- cancer cells
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/389,695 US9107863B2 (en) | 2006-03-27 | 2006-03-27 | Reagents and methods for cancer treatment and prevention |
| US11/389,695 | 2006-03-27 | ||
| PCT/US2007/007526 WO2007126787A2 (en) | 2006-03-27 | 2007-03-27 | Reagents and methods for cancer treatment and prevention |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013170115A Division JP5712257B2 (ja) | 2006-03-27 | 2013-08-20 | 癌の処置および予防のための試薬および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009535298A JP2009535298A (ja) | 2009-10-01 |
| JP2009535298A5 true JP2009535298A5 (https=) | 2011-05-12 |
| JP5422377B2 JP5422377B2 (ja) | 2014-02-19 |
Family
ID=38533710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009502932A Expired - Fee Related JP5422377B2 (ja) | 2006-03-27 | 2007-03-27 | 癌の処置および予防のための試薬および方法 |
| JP2013170115A Expired - Fee Related JP5712257B2 (ja) | 2006-03-27 | 2013-08-20 | 癌の処置および予防のための試薬および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013170115A Expired - Fee Related JP5712257B2 (ja) | 2006-03-27 | 2013-08-20 | 癌の処置および予防のための試薬および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9107863B2 (https=) |
| EP (2) | EP2974738B1 (https=) |
| JP (2) | JP5422377B2 (https=) |
| CN (1) | CN101443036A (https=) |
| AU (1) | AU2007245169B2 (https=) |
| CA (1) | CA2647542A1 (https=) |
| ES (2) | ES2548435T3 (https=) |
| WO (1) | WO2007126787A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3376495B2 (ja) | 1992-08-18 | 2003-02-10 | ソニー株式会社 | 接着剤の塗布方法及び接着治具 |
| US9107863B2 (en) * | 2006-03-27 | 2015-08-18 | The Buck Institute For Age Reasearch | Reagents and methods for cancer treatment and prevention |
| CZ300806B6 (cs) * | 2007-07-18 | 2009-08-12 | Ústav experimentální mediciny AV CR, v.v.i. | Imunostimulacní úcinky trilobolidu a zpusob jeho prípravy |
| CA2903599A1 (en) * | 2013-03-15 | 2014-09-18 | Genspera, Inc. | Methods for making cancer compositions |
| EP2796137A1 (en) * | 2013-04-22 | 2014-10-29 | Universität des Saarlandes | SERCA inhibitor and Calmodulin antagonist combination |
| CN112891354B (zh) * | 2021-03-18 | 2022-10-21 | 新乡医学院 | MDM2抑制剂Nutlin-3a在制备激活内质网应激诱导的癌细胞凋亡药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4867973A (en) * | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| IN165717B (https=) * | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
| US5637483A (en) * | 1991-10-04 | 1997-06-10 | Whitehead Institute For Biomedical Research | Irradiated tumor cell vaccine engineered to express GM-CSF |
| US5904920A (en) * | 1991-10-04 | 1999-05-18 | Whitehead Institute For Biomedical Research | Regulation of systemic immune responses utilizing cytokines and antigens |
| US20010033839A1 (en) * | 1999-10-04 | 2001-10-25 | Emilio Barbera-Guillem | Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation |
| WO2000072686A1 (en) | 1999-06-02 | 2000-12-07 | Cell Genesys, Inc. | Regulation of systemic immune responses utilizing cytokines and antigens |
| JP2001010973A (ja) * | 1999-06-29 | 2001-01-16 | Dnavec Research Inc | がんワクチン |
| NZ517929A (en) * | 1999-09-25 | 2004-02-27 | Univ Iowa Res Found | Immunostimulatory nucleic acids |
| US7056491B2 (en) * | 2000-11-08 | 2006-06-06 | Wisconsin Alumni Research Foundation | Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators |
| CA2356438A1 (en) * | 2001-09-05 | 2003-03-05 | Andre Pichette | Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers |
| EP1441034A4 (en) * | 2001-10-31 | 2006-06-07 | Astellas Pharma Inc | METHOD FOR EVALUATING PHOSPHATASE INHIBITORS |
| WO2003087129A2 (en) * | 2002-04-08 | 2003-10-23 | Siga Technologies, Inc. | Immunogenic peptides, and method of identifying same |
| EP1578459A3 (en) | 2002-10-25 | 2005-11-23 | University of Connecticut Health Center | Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
| ES2469670T3 (es) * | 2003-11-30 | 2014-06-18 | Yeda Research And Development Co., Ltd. | Métodos y agentes para inmunomodulaci�n y métodos para identificar inmunomoduladores |
| US9107863B2 (en) | 2006-03-27 | 2015-08-18 | The Buck Institute For Age Reasearch | Reagents and methods for cancer treatment and prevention |
-
2006
- 2006-03-27 US US11/389,695 patent/US9107863B2/en not_active Expired - Fee Related
-
2007
- 2007-03-27 EP EP15180408.5A patent/EP2974738B1/en not_active Not-in-force
- 2007-03-27 AU AU2007245169A patent/AU2007245169B2/en not_active Ceased
- 2007-03-27 WO PCT/US2007/007526 patent/WO2007126787A2/en not_active Ceased
- 2007-03-27 ES ES07754097.9T patent/ES2548435T3/es active Active
- 2007-03-27 CA CA002647542A patent/CA2647542A1/en not_active Abandoned
- 2007-03-27 EP EP07754097.9A patent/EP2004219B1/en not_active Not-in-force
- 2007-03-27 ES ES15180408.5T patent/ES2655909T3/es active Active
- 2007-03-27 CN CNA2007800162837A patent/CN101443036A/zh active Pending
- 2007-03-27 JP JP2009502932A patent/JP5422377B2/ja not_active Expired - Fee Related
-
2010
- 2010-04-29 US US12/770,638 patent/US8895031B2/en active Active
-
2013
- 2013-08-20 JP JP2013170115A patent/JP5712257B2/ja not_active Expired - Fee Related
-
2015
- 2015-07-15 US US14/800,412 patent/US9885704B2/en not_active Expired - Fee Related
-
2017
- 2017-12-22 US US15/852,606 patent/US20180128816A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7055906B2 (ja) | 細胞膜透過性を増加させるための交流電界の使用 | |
| Sultan et al. | Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial | |
| US20190099398A1 (en) | Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour | |
| Jiang et al. | Preparation and anti-tumor metastasis of carboxymethyl chitosan | |
| MX336710B (es) | Oligoribonucleotidos y metodos de uso de los mismos para tratamiento de la alopecia, insuficiencia renal aguda y otras enfermedades. | |
| BRPI0601736A (pt) | métodos de terapia adjuvante, método de cura de cáncer de mama não metastático, método de redução de reincidência de doenças, método de instrução de pacientes humanos com cáncer de mama her2-positivo não metastático, método de produção e métodos comerciais | |
| GB0223380D0 (en) | Combination therapy | |
| NO20060307L (no) | Anvendelse av kinoazolinderivatet ZD6474 kombinert med platinaforbindelser og eventuelt ioniserende straling i behandling av sykdommer assosoiert med angiogenese og/eller okt vaskulaert permeabilitet | |
| DE60331933D1 (de) | Benutzung von alpha (1,3) -galactosyltransferase exprimierenden allogenen tumorzellen zur impfung gegen tumoren | |
| MX383644B (es) | Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion. | |
| JP2009535298A5 (https=) | ||
| NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
| WO2004073657A3 (en) | Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases | |
| IL191796A0 (en) | Combination of zd6474 and pemetrexed | |
| Farooqi | Regulation of deregulated cell signaling pathways by pomegranate in different cancers: Re-interpretation of knowledge gaps | |
| ATE418965T1 (de) | Medikamentöse gezielte lokale lipolyse | |
| CY1111353T1 (el) | Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης | |
| Xu et al. | Endothelial Foxo1 Phosphorylation Inhibition via Aptamer‐Liposome Alleviates OPN‐Induced Pathological Vascular Remodeling Following Spinal Cord Injury | |
| DE60311788D1 (de) | Kombinationstherapie zur behandlung von krebs | |
| PL1653964T3 (pl) | Skojarzone leczenie raka obejmujące AZD2171 i ZD1839 | |
| ATE502641T1 (de) | Kombination aus azd2171 und pemetrexed | |
| IL177953A0 (en) | Combination therapy including azd2171 and a taxane | |
| GB0406446D0 (en) | Combination therapy | |
| IL172682A0 (en) | Combination therapy | |
| BRPI0508959A (pt) | uso de azd2171 ou de um sal do mesmo farmaceuticamente aceitável, uso de sal maleato de azd2171 e oxaliplatina, composição farmacêutica, kit, e, método para a produção de um efeito antiangiogênico e/ou de redução da permeabilidade vascular em um animal de sangue quente |